Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$72.2M |
| 2 |
Microsoft
MSFT
|
+$66.1M |
| 3 |
Under Armour
UAA
|
+$63.2M |
| 4 |
ExxonMobil
XOM
|
+$51.6M |
| 5 |
WCN
Waste Connections
WCN
|
+$51.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.47% |
| 2 | Technology | 14.08% |
| 3 | Financials | 13.83% |
| 4 | Industrials | 10.22% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Vitamin Cottage Natural Grocers
NGVC
$654M
| $766K | ﹤0.01% |
58,746
+663
| +1% | +$9.79K |
|
|
GNBC
2952
DELISTED
Green Bancorp, Inc
GNBC
| $766K | ﹤0.01% |
87,868
+10,094
| +13% | +$81.6K |
|
|
CFMS
2953
DELISTED
Conformis, Inc. Common Stock
CFMS
| $764K | ﹤0.01% |
4,357
+1,242
| +40% | +$292K |
|
2954
Codexis
CDXS
$158M
| $763K | ﹤0.01% |
189,435
+49,848
| +36% | +$183K |
|
|
STML
2955
DELISTED
Stemline Therapeutics, Inc.
STML
| $762K | ﹤0.01% |
112,699
+1,790
| +2% | +$11.3K |
|
2956
NRC Health Common Stock
NRC
$450M
| $761K | ﹤0.01% |
55,560
+753
| +1% | +$10.6K |
|
2957
PDS Biotechnology
PDSB
$43.4M
| $760K | ﹤0.01% |
3,760
+423
| +13% | +$74.8K |
|
|
ANTH
2958
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $757K | ﹤0.01% |
30,657
+406
| +1% | +$11.5K |
|
2959
Silicon Motion
SIMO
$8.68B
| $753K | ﹤0.01% |
15,766
-7,411
| -32% | -$311K |
|
2960
INNOVATE Corp
VATE
$165M
| $753K | ﹤0.01% |
17,518
+970
| +6% | +$39.2K |
|
2961
Alico
ALCO
$283M
| $751K | ﹤0.01% |
24,858
+493
| +2% | +$14.2K |
|
|
ITIC
2962
Investors Title Co
ITIC
$547M
| $748K | ﹤0.01% |
7,859
+1,396
| +22% | +$131K |
|
|
PRTK
2963
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $748K | ﹤0.01% |
53,811
+2,868
| +6% | +$42.2K |
|
2964
Southern Missouri Bancorp
SMBC
$850M
| $747K | ﹤0.01% |
31,763
+6,609
| +26% | +$159K |
|
2965
Ambev
ABEV
$46.4B
| $746K | ﹤0.01% |
126,315
-31,660
| -20% | -$170K |
|
2966
AppFolio
APPF
$7.04B
| $746K | ﹤0.01% |
51,608
+9,994
| +24% | +$133K |
|
|
EAGLU
2967
DELISTED
Double Eagle Acquisition Corp.
EAGLU
| $744K | ﹤0.01% |
75,000
-49,900
| -40% | -$496K |
|
2968
KVH Industries
KVHI
$157M
| $741K | ﹤0.01% |
96,251
+616
| +0.6% | +$5.36K |
|
2969
Gaia
GAIA
$48.4M
| $739K | ﹤0.01% |
95,598
+8,389
| +10% | +$59.9K |
|
|
DCOY
2970
Decoy Therapeutics
DCOY
$2.09M
| – | – |
0
| – | – |
|
2971
Banco Santander
SAN
$210B
| $736K | ﹤0.01% |
195,991
+24,492
| +14% | +$106K |
|
|
TMUSP
2972
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| – | – |
0
| – | – |
|
2973
ReposiTrak
TRAK
$159M
| $727K | ﹤0.01% |
81,101
+3,198
| +4% | +$29.3K |
|
2974
LCNB Corp
LCNB
$283M
| $725K | ﹤0.01% |
45,902
+9,182
| +25% | +$154K |
|
2975
CPI Card Group
PMTS
$320M
| $724K | ﹤0.01% |
28,910
+1,468
| +5% | +$45.2K |
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, up 97,477% from $188M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management's Q2 2016 filing shows 96 new, 2,386 increased, 984 reduced and 127 closed positions. Its largest new stake was S&P Global: 2,009,728 shares worth $215M. The largest sale was GE Aerospace, an estimated $72.2M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53M.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value rose 97,477% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.